Roche

We advance science so that we all have more time with the people we love.
Read our community guidelines:

[Roche @Roche]

Hi Francesco

Thank you for reaching out. We are very sorry to hear about your story. We recommend you to consult our website for clinical trials: https://t.co/QmUqYzppzA
Of course next to the website we also recommend to discuss it with your healthcare professional as they have the best information and knowledge about your medical history.

Wishing you all the very best.
Ana at Team Roche

[Roche @Roche]

¡Hola, Beto! Muchas gracias por escribirnos. Para poder brindarte el mejor soporte posible con tu caso, te pedimos que nos compartas los detalles a través de este formulario: https://t.co/WdE8rSBI6U. Además, recuerda que nuestro equipo de atención en diabetes está disponible para orientarte; puedes encontrar tu oficina más cercana en este enlace: https://t.co/AW2re2VVWd.

Ken del Equipo Roche

[Roche @Roche]

Thank you for your interest in Roche, if you would like to apply for a position/internship with Roche please visit our careers site where you can apply directly online for any vacancies that match your search criteria.
https://t.co/BjTN1mzAHA

If there are no current vacancies that meet your criteria, you have the opportunity to join the Roche Talent Pool. By joining the Roche Talent Pool you are registering your interest in joining Roche.
https://t.co/hM9jRPqGkd

Wishing you all the very best with your application.
Ana at Team Roche

[Roche @Roche]

Roche’s Women as Visionaries in Eyecare (#WAVE) initiative connects women in ophthalmology whose work, experience and ambition are helping shape eyecare. If you’re at #EURETINA2026, join us at the Roche booth for inspiring talks and to connect with a community working to move the field forward.

#EURETINA26

[Roche @Roche]

HR-positive #BreastCancer is the most common subtype, but early-stage recurrence and progression following initial therapies remain a reality for many.
Together, we’re working to help change this.

[Roche @Roche]

At Roche our commitment to #BreastCancer research has been guided by science and a dedication to improving outcomes for people living with cancer. 🧵👇

[Roche @Roche]

We continue to focus our scientific efforts on areas of high unmet need, aiming to translate research insights into meaningful health solutions.

[Roche @Roche]

To move retinal care forward, we must understand how solutions perform in everyday practice.

As @EURETINA 2026 continues, Nilesh Mehta, Therapeutic Area Head, Ophthalmology at Roche, is sharing what our latest real-world evidence could mean for patients with neovascular age-related macular degeneration (#nAMD) and diabetic macular edema (#DME).

#EURETINA26

[Roche @Roche]

@HI7742 Thank you for your interest in Roche! Just follow the link to see what roles are open: https://t.co/N3XQlX3q0b. If there’s nothing that suits you right now, sign up to our talent pool so we can contact you in the future: https://t.co/O2qs12VQST.

Ana at team Roche

[Roche @Roche]

#MEDIA – We are pleased that the New England Journal of Medicine has published phase III data demonstrating significant progression-free survival benefit with our investigational medicine for people with ER-positive advanced #BreastCancer.

Read more here👉https://t.co/0CHqNzugQ7

$ROG $RHHBY

[Roche @Roche]

Expanding the possible starts with fresh ideas, emerging leaders and new perspectives. The Leading Edge Incubator (LEI) is designed to empower the next generation shaping the future of ophthalmology.

Attending #EURETINA26? Stop by the Roche booth to meet current LEI members and learn about innovations from the 2025-26 cohort.

#EURETINA2026

[Roche @Roche]

#MEDIA – At #EURETINA2026, we’re pleased to share new real-world data confirming effectiveness and safety across major retinal conditions, including nAMD, DME and RVO.

[Roche @Roche]

#MEDIA – We are pleased that the U.S. FDA has accepted the new drug application for our investigational medicine for both relapsing and primary progressive multiple sclerosis.

Read here 👉 https://t.co/tqbYC4W1To

#multiplesclerosis #MS

[Roche @Roche]

Weak circulating tumor DNA (ctDNA) signals remain a primary bottleneck in minimal residual disease research. Roche’s sequencing by expansion (SBX) achieves the throughput necessary to bypass standard resolution limits. Discover more: https://t.co/2xIWPpVrQg

(Research use only)

#NGS #Genomics #Innovation #MakeSpaceWithSBX #RocheSBX

[Roche @Roche]

@2ae95c8c1fe0429 Hi Prateek, as you are not following us, we cannot send you a direct message. Please reach out to us at 1800 120 6020 or [email protected], so our team can help address your concerns directly.

Kat at Team Roche

[Roche @Roche]

@HI7742 Hi there, thank you for your interest in Roche 🙏 Just follow the link to see what roles are open: https://t.co/N3XQlX3q0b

Kat at Team Roche

[Roche @Roche]

Better cancer outcomes shouldn't demand bigger budgets—they demand smarter innovation.

Reflecting on this year's World Cancer Congress, the path forward is clear: the real cost of cancer isn’t just treatment, but the time stolen from families when care comes too late.

By prioritising earlier diagnosis and care closer to home, we don't just free up hospital capacity. We change the equation entirely—turning progress into healthy years of life.

#WhatsItWorth #WCC2026 #GlobalHealth

[Roche @Roche]

Hi Louise

Thank you for getting in touch with https://t.co/9HEamcLmL1 ensure that the right team takes care of your request, we would invite you to get in touch with our office in your country. You can find a list of all Roche offices at this link: https://t.co/AJXxzupqSU
Or contact us at https://t.co/53pdlSvuJP

Wishing you all the very best.
Ana at Team Roche

[Roche @Roche]

Breast cancer care shouldn't depend on where you live.

At this year's World Cancer Congress, the message was clear: regional collaboration is key to ensuring every woman gets the care she deserves, no matter where she lives.

By working across borders to bring diagnosis and treatment closer to home, we can turn progress into time—time for women to keep pursuing their dreams.

#WhatsItWorth #WCC2026 #GlobalHealth